Clinical Trial Update: A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions [Phase 2]

View source ↗

Summary

Phase 2 trial update for LiRIS in females with interstitial cystitis with Hunner's lesions shows completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis Interstitial
• Interstitial Cystitis
• Ulcer

Drugs mentioned

• LiRIS

Snippet

Sponsor: Allergan | Conditions: Cystitis, Interstitial, Ulcer | Phase 2 | Status: COMPLETED | Results posted: 2018-10-05